INFLUENCE OF VIRAL QUASI-SPECIES ON EFFECTIVENESS OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C PATIENTS

被引:153
作者
KANAZAWA, Y [1 ]
HAYASHI, N [1 ]
MITA, E [1 ]
LI, TC [1 ]
HAGIWARA, H [1 ]
KASAHARA, A [1 ]
FUSAMOTO, H [1 ]
KAMADA, T [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT MED 1,SUITA,OSAKA 565,JAPAN
关键词
D O I
10.1002/hep.1840200504
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The quasispecies nature of hepatitis C virus genome distribution is most evident in hypervariable regions of the putative envelope 2 domain. Eight patients with chronic hepatitis C treated with interferon-alpha were studied as to heterogeneity of the hypervariable regions to clarify the implications of quasispecies. More than 10 recombinant clones generated from polymerase chain reaction-amplified products of the hypervariable regions were sequenced. The sets of clones derived from long-term responders before interferon therapy showed a significantly lower (p < 0.05) degree of sequence complexity of the hypervariable region 1 quasispecies than those from short-term ones or non responders. The values of nucleotide diversity (the average number of nucleotide differences per site between two randomly chosen sequences) in hypervariable region 1 before interferon therapy were also significantly lower (p < 0.05) for long-term responders (mean, 2.31 x 10(-2)) than for short-term ones or nonresponders (13.02 x 10(-2)). In some cases, nucleotide diversity decreased remarkably during interferon therapy, whereas the values remained unchanged in other cases. In one interesting case, a short-term response was first noted with the nucleotide diversity decreasing from 13.98 x 10(-2) to 0.21 x 10(-2); namely, the diversity of the quasispecies was significantly reduced, and then a long-term response was observed after an additional course of interferon therapy. Thus, the degree of quasispecies' complexity and diversity of hypervariable region 1 was closely correlated with the responsiveness to interferon therapy in chronic hepatitis C patients, and thus may have some influence on interferon efficacy.
引用
收藏
页码:1121 / 1130
页数:10
相关论文
共 45 条
[1]  
[Anonymous], 1987, MOL EVOLUTIONARY GEN, DOI DOI 10.7312/NEI-92038
[2]   TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].
DAVIS, GL ;
BALART, LA ;
SCHIFF, ER ;
LINDSAY, K ;
BODENHEIMER, HC ;
PERRILLO, RP ;
CAREY, W ;
JACOBSON, IM ;
PAYNE, J ;
DIENSTAG, JL ;
VANTHIEL, DH ;
TAMBURRO, C ;
LEFKOWITCH, J ;
ALBRECHT, J ;
MESCHIEVITZ, C ;
ORTEGO, TJ ;
GIBAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506
[3]   RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DIBISCEGLIE, AM ;
MARTIN, P ;
KASSIANIDES, C ;
LISKERMELMAN, M ;
MURRAY, L ;
WAGGONER, J ;
GOODMAN, Z ;
BANKS, SM ;
HOOFNAGLE, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1506-1510
[4]   THE QUASISPECIES (EXTREMELY HETEROGENEOUS) NATURE OF VIRAL-RNA GENOME POPULATIONS - BIOLOGICAL RELEVANCE - A REVIEW [J].
DOMINGO, E ;
MARTINEZSALAS, E ;
SOBRINO, F ;
DELATORRE, JC ;
PORTELA, A ;
ORTIN, J ;
LOPEZGALINDEZ, C ;
PEREZBRENA, P ;
VILLANUEVA, N ;
NAJERA, R ;
VANDEPOL, S ;
STEINHAUER, D ;
DEPOLO, N ;
HOLLAND, J .
GENE, 1985, 40 (01) :1-8
[5]  
EIGEN M, 1988, RNA GENETICS, P211
[6]   ESTIMATION OF AVERAGE NUMBER OF NUCLEOTIDE SUBSTITUTIONS WHEN THE RATE OF SUBSTITUTION VARIES WITH NUCLEOTIDE [J].
GOJOBORI, T ;
ISHII, K ;
NEI, M .
JOURNAL OF MOLECULAR EVOLUTION, 1982, 18 (06) :414-423
[7]   DETECTION OF HEPATITIS-C VIRUS-RNA IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
UEDA, K ;
TAKEHARA, T ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
HEPATOLOGY, 1992, 15 (01) :37-41
[8]   QUANTITATIVE-ANALYSIS OF HEPATITIS-C VIRUS-RNA IN SERUM DURING INTERFERON ALFA THERAPY [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
TAKEHARA, T ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
GASTROENTEROLOGY, 1993, 104 (03) :877-883
[9]  
HAMMING R, 1980, CODING INFORMATION T
[10]   HYPERVARIABLE REGIONS IN THE PUTATIVE GLYCOPROTEIN OF HEPATITIS-C VIRUS [J].
HIJIKATA, M ;
KATO, N ;
OOTSUYAMA, Y ;
NAKAGAWA, M ;
OHKOSHI, S ;
SHIMOTOHNO, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (01) :220-228